司库奇尤-话题@MedSci

#司库奇尤#

8篇内容 | 765人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1949737, encodeId=ad0f1949e374f, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=Heidelb:阿达木和司库奇尤治疗银屑病患者的结核病阳性转换率研究, objectType=article, longId=728032, objectId=4973e28032a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4973e28032a7, replyNumber=0, likeNumber=45, createdTime=2022-12-02, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4973e28032a7, moduleTitle=Heidelb:阿达木和司库奇尤治疗银屑病患者的结核病阳性转换率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4973e28032a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949735, encodeId=417b1949e35ba, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性, objectType=article, longId=216936, objectId=12a7216936f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a7216936f0, replyNumber=0, likeNumber=34, createdTime=2021-11-18, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a7216936f0, moduleTitle=BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a7216936f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949734, encodeId=497b1949e34e6, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=BJD：司库奇尤单抗每周两次与每周四次给药对斑块型银屑病患者的疗效分析, objectType=article, longId=216700, objectId=d213216e0075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d213216e0075, replyNumber=0, likeNumber=34, createdTime=2022-04-01, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d213216e0075, moduleTitle=BJD：司库奇尤单抗每周两次与每周四次给药对斑块型银屑病患者的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d213216e0075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949736, encodeId=d4ca1949e3640, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=BJD:司库奇尤单抗治疗中重度掌跖银屑病的持续疗效观察, objectType=article, longId=216937, objectId=747821693e12, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=747821693e12, replyNumber=0, likeNumber=40, createdTime=2022-01-23, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=747821693e12, moduleTitle=BJD:司库奇尤单抗治疗中重度掌跖银屑病的持续疗效观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=747821693e12)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949733, encodeId=42971949e3377, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎, objectType=article, longId=196033, objectId=9dbe1960331f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dbe1960331f, replyNumber=0, likeNumber=49, createdTime=2020-09-07, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dbe1960331f, moduleTitle=FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dbe1960331f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949732, encodeId=f7eb1949e32f9, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=可善挺（司库奇尤单抗）强直性脊柱炎适应症获批, objectType=article, longId=193217, objectId=d1c619321e2d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c619321e2d, replyNumber=0, likeNumber=47, createdTime=2020-11-05, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c619321e2d, moduleTitle=可善挺（司库奇尤单抗）强直性脊柱炎适应症获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c619321e2d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949730, encodeId=3f741949e3060, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布, objectType=article, longId=161713, objectId=446d161e139c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=446d161e139c, replyNumber=0, likeNumber=51, createdTime=2019-09-27, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=446d161e139c, moduleTitle=诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=446d161e139c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1949731, encodeId=770b1949e317d, content=<a href='/topic/show?id=25ce38e2130' target=_blank style='color:#2F92EE;'>#司库奇尤#</a>, objectTitle=司库奇尤单抗用于急性进行期银屑病的治疗, objectType=article, longId=176399, objectId=f03e1e6399ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03e1e6399ab, replyNumber=0, likeNumber=36, createdTime=2020-04-27, rootId=0, userName=jeanqiuqiu, userId=6f7770, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03e1e6399ab, moduleTitle=司库奇尤单抗用于急性进行期银屑病的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f03e1e6399ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

司库奇尤

2020-05-29

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

Heidelb:阿达木和司库奇尤治疗银屑病患者的结核病阳性转换率研究

2022-12-02

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性

2021-11-18

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

BJD：司库奇尤单抗每周两次与每周四次给药对斑块型银屑病患者的疗效分析

2022-04-01

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

BJD:司库奇尤单抗治疗中重度掌跖银屑病的持续疗效观察

2022-01-23

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎

2020-09-07

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

可善挺（司库奇尤单抗）强直性脊柱炎适应症获批

2020-11-05

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

诺华司库奇尤单抗（俗称“苏金单抗”）中国数据首度发布

2019-09-27

jeanqiuqiu (审核中...)

前往app查看评论内容

#司库奇尤#

司库奇尤单抗用于急性进行期银屑病的治疗

2020-04-27

科室
- - 订阅+
  - 更多科室
工具
服务